GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Operating Margin %

American Vietnamese Biotech (HSTC:AMV) Operating Margin % : 0.00% (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. American Vietnamese Biotech's Operating Income for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's Operating Margin % for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for American Vietnamese Biotech's Operating Margin % or its related term are showing as below:


HSTC:AMV's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -166.59
* Ranked among companies with meaningful Operating Margin % only.

American Vietnamese Biotech's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

American Vietnamese Biotech's Operating Income for the three months ended in . 20 was ₫0.00 Mil.


American Vietnamese Biotech Operating Margin % Historical Data

The historical data trend for American Vietnamese Biotech's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Operating Margin % Chart

American Vietnamese Biotech Annual Data
Trend
Operating Margin %

American Vietnamese Biotech Quarterly Data
Operating Margin %

Competitive Comparison of American Vietnamese Biotech's Operating Margin %

For the Biotechnology subindustry, American Vietnamese Biotech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Vietnamese Biotech's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's Operating Margin % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's Operating Margin % falls into.



American Vietnamese Biotech Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

American Vietnamese Biotech's Operating Margin % for the fiscal year that ended in . 20 is calculated as

Operating Margin %=Operating Income (A: . 20 ) / Revenue (A: . 20 )
= /
= %

American Vietnamese Biotech's Operating Margin % for the quarter that ended in . 20 is calculated as

Operating Margin %=Operating Income (Q: . 20 ) / Revenue (Q: . 20 )
= /
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Vietnamese Biotech  (HSTC:AMV) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


American Vietnamese Biotech Operating Margin % Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles to Present Strategies to Build and Expand Charging Infrastructure

By Stock market mentor Stock market mentor 01-19-2023